Breaking News Instant updates and real-time market news.

2020-07-13 12:41:20 ITJTY Intrum $0.00 / + (+0.00%) 12:41 07/13/20 07/13 12:41 07/13/20 12:41	JPMorgan backs Neutral on Intrum after Q2 pre-announcement JPMorgan analyst Gurjit Kambo reiterated a Neutral rating and SEK 140 price target on Intrum after the company pre-announced Q2 results.
ITJTY Intrum $0.00 / + (+0.00%) 07/13/20 UBS Intrum Q2 pre-announcement better-than-expected, says UBS 05/13/20 UBS Intrum price target lowered to SEK 135 from SEK 165 at UBS 03/31/20 JPMorgan Intrum price target lowered to SEK 155 from SEK 295 at JPMorgan

2020-07-13 12:41:20

ITJTY

Intrum

$0.00 / + (+0.00%)

12:41

07/13/20

07/13

12:41

07/13/20

12:41

JPMorgan backs Neutral on Intrum after Q2 pre-announcement

JPMorgan analyst Gurjit Kambo reiterated a Neutral rating and SEK 140 price target on Intrum after the company pre-announced Q2 results.

ITJTY Intrum

$0.00 / + (+0.00%)

07/13/20 UBS: Intrum Q2 pre-announcement better-than-expected, says UBS

05/13/20 UBS: Intrum price target lowered to SEK 135 from SEK 165 at UBS

03/31/20 JPMorgan: Intrum price target lowered to SEK 155 from SEK 295 at JPMorgan

TODAY'S FREE FLY STORIES

Syndicate	Lithium Americas 15.9M share Spot Secondary priced at $22.00 » 08:06 01/20/21 01/20 08:06 01/20/21 08:06 LAC Lithium Americas $26.80 / +6.27 (+30.54%) The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $26.80 / +6.27 (+30.54%) 07:50 Today Lithium Americas trading halted, news pending 01/19/21 Lithium Americas rises 30.6% 01/19/21 Lithium Americas rises 19.6% 01/19/21 Lithium Americas rises 15.7% LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $26.80 / +6.27 (+30.54%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names
Hot Stocks	Ocular Therapeutix to present new OTX-TIC data at Glaucoma 360 Forum » 08:06 01/20/21 01/20 08:06 01/20/21 08:06 OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) Ocular Therapeutix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/22/20 Ocular Therapeutix submits Dextenza sNDA to FDA 11/04/20 Ocular Therapeutix receives permanent category I CPT code from AMA 10/30/20 Ocular Therapeutix announces Dextenza, OTX-TIC license agreement with AffaMed 10/13/20 Ocular Therapeutix reaches agreement w/ FDA on ReSure retrospective study OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/30/20 JMP Securities Ocular Therapeutix price target raised to $30 from $20 at JMP Securities 12/28/20 Fly Intel: Top five analyst calls 12/28/20 H.C. Wainwright Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright 12/21/20 Piper Sandler Ocular Therapeutix price target raised to $28 from $16 at Piper Sandler OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 11/05/20 Ocular Therapeutix reports Q3 EPS (21c), consensus (24c) 10/07/20 Ocular Therapeutix reports preliminary Q3 revenue $5.8M-$5.9M, consensus $3.91M 08/07/20 Ocular Therapeutix reports Q2 EPS (64c), consensus (31c) 16 Dec 14 Oct 20 May OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/28/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers
Earnings	EDAP TMS reports preliminary 2020 revenue EUR41.6M vs. EUR44.9M last year 08:06 01/20/21 01/20 08:06 01/20/21 08:06 EDAP EDAP TMS $6.81 / +0.14 (+2.10%) ShowHide Related Items >><< Company News Street Research Earnings EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/14/21 EDAP TMS announces 24 month interim results of AFU sponsored study 01/06/21 EDAP TMS CEO says sales pipeline continues to grow entering 2021 12/30/20 EDAP TMS announces two Focal One sales to healthcare institutions 12/09/20 EDAP TMS announces final U.S. 2021 reimbursement rules for HIFU EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/12/21 B. Riley Securities EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities 04/15/20 Fly Intel: Top five analyst initiations 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 08:05 Today EDAP TMS reports preliminary Q4 revenue EUR15.3M vs. EUR12M last year 08/26/20 EDAP TMS reports Q2 EPS (EUR0.01) vs. EUR0.05 a year ago
Hot Stocks	CSG names Channing Martin Jones chief diversity, social responsibility officer » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 CSGS CSG $44.40 / +1.2 (+2.78%) CSG announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CSGS CSG $44.40 / +1.2 (+2.78%) 12/01/20 CSG extends partnership with Airtel Africa 11/04/20 CSG expands relationship with Inmarsat 09/29/20 CSG's Forte Payment System in strategic pact with Accela 08/31/20 CSG CEO Bret Griess to step down, Brian Shepherd named CEO CSGS CSG $44.40 / +1.2 (+2.78%) 09/10/20 B. Riley FBR CSG pullback brings attractive entry point, says B. Riley FBR 03/10/20 Sidoti CSG upgraded to Buy from Neutral at Sidoti CSGS CSG $44.40 / +1.2 (+2.78%) 11/04/20 CSG backs FY20 EPS view of $2.87-$3.10, two estimates $3.02 11/04/20 CSG reports Q3 EPS 76c, two estimates 79c 08/05/20 CSG backs FY20 EPS view of $.287-$3.10, consensus $3.05 08/05/20 CSG reports Q2 EPS 59c, consensus 70c 02/03/21 CSG - CSGS
Recommendations	Netflix price target raised to $650 from $610 at Jefferies » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 NFLX Netflix $501.85 / +3.9 (+0.78%) Jefferies analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 08:04 Today Barclays Netflix price target raised to $650 from $550 at Barclays 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st

Earnings	EDAP TMS reports preliminary Q4 revenue EUR15.3M vs. EUR12M last year » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 EDAP EDAP TMS $6.81 / +0.14 (+2.10%) Marc Oczachowski,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/14/21 EDAP TMS announces 24 month interim results of AFU sponsored study 01/06/21 EDAP TMS CEO says sales pipeline continues to grow entering 2021 12/30/20 EDAP TMS announces two Focal One sales to healthcare institutions 12/09/20 EDAP TMS announces final U.S. 2021 reimbursement rules for HIFU EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/12/21 B. Riley Securities EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities 04/15/20 Fly Intel: Top five analyst initiations 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 08/26/20 EDAP TMS reports Q2 EPS (EUR0.01) vs. EUR0.05 a year ago
Recommendations	Netflix price target raised to $650 from $550 at Barclays » 08:04 01/20/21 01/20 08:04 01/20/21 08:04 NFLX Netflix $501.85 / +3.9 (+0.78%) Barclays analyst Kannan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank 07:23 Today Cowen Netflix price target raised to $675 from $650 at Cowen NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Hot Stocks	Clarivate Analytics changing ticker symbol to "CLVT" February 1 » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) Clarivate's ticker… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 11/30/20 Clarivate Analytics acquires Hanlim IPS 11/09/20 Clarivate Analytics divests Techstreet to ASME 09/01/20 Clarivate Analytics enters partnership with IP DESK 08/27/20 Clarivate Analytics appoints Stefano Maestri as Chief Technology Officer CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 10/15/20 Goldman Sachs Clarivate Analytics reinstated with a Buy at Goldman Sachs 10/14/20 Morgan Stanley Clarivate Analytics initiated with an Equal Weight at Morgan Stanley 10/02/20 Barclays Clarivate Analytics price target raised to $35 from $26 at Barclays 08/04/20 Citi Clarivate Analytics price target raised to $33 from $28 at Citi CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 11/25/20 Clarivate Analytics raises 2020 adjusted EPS view to 55c-61c from 53c-59c 11/25/20 Clarivate Analytics sees 2021 adjusted EPS 73c-79c, consensus 78c 10/29/20 Clarivate Analytics raises FY20 adj. EPS view to 55c-61c from 53c-59c 10/29/20 Clarivate Analytics reports Q3 adj. EPS 14c, consensus 15c 04 Jun 06 Feb 02/25/21 Clarivate Analytics - CCC
Downgrade	Healthcare Trust downgraded to Equalweight from Overweight at Capital One » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 HTA Healthcare Trust $28.21 / -0.365 (-1.28%) Capital One downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 01/12/21 Healthcare Trust reports acquisition of $129M of medical office investments 09/22/20 Healthcare Trust reactivates share repurchase program HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 01/13/21 Jefferies Healthcare Trust price target raised to $35 from $33 at Jefferies 01/13/21 Jefferies Healthcare Realty Trust upgraded to Buy with sector 'unscathed' at Jefferies 12/21/20 JPMorgan JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021 12/21/20 JPMorgan Healthcare Trust downgraded to Neutral from Overweight at JPMorgan HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 11/03/20 Healthcare Trust reports Q3 normalized FFO 43c, consensus 42c 08/06/20 Healthcare Trust reports Q2 normalized FFO 42c, consensus 42c
Recommendations	Goldman Sachs price target raised to $335 from $320 at Wells Fargo » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 GS Goldman Sachs $294.20 / -6.85 (-2.28%) Wells Fargo analyst Mike… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Goldman Sachs: Investment banking backlog at near-record levels 01/19/21 Goldman Sachs evaluating whether more staff can be moved to strategic locations 01/19/21 Goldman Sachs plans to resume share repurchases this quarter 01/19/21 Goldman Sachs plans to accelerate pace of asset sales GS Goldman Sachs $294.20 / -6.85 (-2.28%) 07:37 Today Oppenheimer Goldman Sachs price target raised to $445 from $407 at Oppenheimer 07:15 Today BMO Capital Goldman Sachs price target raised to $330 from $307 at BMO Capital 06:35 Today RBC Capital Goldman Sachs price target raised to $319 from $225 at RBC Capital 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/25/21 REITwise 2021 Virtual Conference GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd

Hot Stocks	Seneca Biopharma reports data from Phase 2 study of NSI-566 in China » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 SNCA Seneca Biopharma $1.34 / + (+0.00%) Seneca Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SNCA Seneca Biopharma $1.34 / + (+0.00%) 01/13/21 Leading BioSciences announces Fast Track Designation for LB1148 01/08/21 Leading BioSciences announces topline data from gastrointestinal surgery study 12/17/20 Seneca Biopharma trading resumes 12/17/20 Seneca Biopharma, Leading BioSciences to merge in all-stock transaction
Hot Stocks	Gritstone, Genevant announce license agreement for COVID-19 vaccine » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) Gritstone Oncology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 01/19/21 Gritstone Oncology signs agreement with NIAID to begin testing COVID-19 vaccine 01/04/21 EcoR1 Capital reports 9.99% passive stake in Gritstone Oncology 12/28/20 Gritstone Oncology announces private placement financings totaling $125M 12/23/20 Gritstone Oncology announces $110M private placement GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 06:25 Today H.C. Wainwright Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright 05:31 Today Baird Gritstone Oncology downgraded to Underperform from Outperform at Baird 07/14/20 BTIG Gritstone Oncology price target lowered to $17 from $31 at BTIG GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 11/05/20 Gritstone Oncology reports Q3 EPS (69c), consensus (64c) 08/05/20 Gritstone Oncology reports Q2 EPS (69c), consensus (73c)
Hot Stocks	F-star Therapeutics receives european patent for FS118 molecule » 08:02 01/20/21 01/20 08:02 01/20/21 08:02 FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) F-star Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) 01/04/21 F-star Therapeutics doses first patient in FS222 Phase 1 trial 12/03/20 F-star Therapeutics doses first patient in Phase 1 clinical trial of FS120 11/30/20 Glaxosmithkine reports 8.9% passive stake in F-star Therapeutics FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) 12/02/20 Ladenburg F-star Therapeutics initiated with a Buy at Ladenburg
Recommendations	Advanced Drainage price target raised to $98 from $89 at Barclays » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 WMS Advanced Drainage $89.44 / +0.15 (+0.17%) Barclays analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 08/06/20 Advanced Drainage sees FY21 CapEx $60M-$65M WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 12/18/20 Barclays Advanced Drainage price target raised to $89 from $77 at Barclays 12/16/20 Loop Capital Advanced Drainage price target raised to $88 from $75 at Loop Capital 10/12/20 Barclays Advanced Drainage price target raised to $77 from $64 at Barclays 10/07/20 Loop Capital Advanced Drainage price target raised to $75 from $67 at Loop Capital WMS Advanced Drainage $89.44 / +0.15 (+0.17%) 11/05/20 Advanced Drainage sees FY21 revenue $1.79B-$1.84B, consensus $1.82B 11/05/20 Advanced Drainage reports Q2 EPS 93c, consensus $1.05 08/06/20 Advanced Drainage reports Q1 EPS 83c, consensus 68c 11 Dec 02/04/21 Advanced Drainage - WMS
Downgrade	Redfin downgraded to Neutral from Buy at DA Davidson » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 RDFN Redfin $76.64 / -0.08 (-0.10%) DA Davidson analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options RDFN Redfin $76.64 / -0.08 (-0.10%) 01/06/21 Redfin expands RedfinNow to Phoenix 10/13/20 Redfin reports U.S. luxury home sales increased 41.5% in Q3 09/11/20 Redfin says U.S. median home sale prices up 13% from last year 08/14/20 Tiger Global takes stake in ZoomInfo during Q2, exits iQIYI RDFN Redfin $76.64 / -0.08 (-0.10%) 01/19/21 Truist Truist keeps Buys on Redfin, Zillow into 'strong' 2021 housing start 01/12/21 BTIG Redfin downgraded to Neutral from Buy at BTIG, prefers Zillow Group 01/12/21 BTIG Redfin downgraded to Neutral from Buy at BTIG 01/06/21 Wedbush Redfin price target raised to $86 from $59 at Wedbush RDFN Redfin $76.64 / -0.08 (-0.10%) 11/06/20 Redfin reported Q3 EPS 30c, consensus 25c 11/05/20 Redfin sees Q4 revenue $226M-$233M, consensus $214.94M 11/05/20 Notable companies reporting after market close 10/15/20 Redfin sees Q3 revenue $235.0M, consensus $222.7M RDFN Redfin $76.64 / -0.08 (-0.10%) 08/13/20 Cost of mortgage refinancing 'about to go up,' NY Times reports RDFN Redfin $76.64 / -0.08 (-0.10%) 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 12/21/20 Microsoft, Walmart upgrades among today's top calls on Wall Street 11/05/20 Fly Intel: After-Hours Movers 09/25/20 Cruise Line upgrades among today's top calls on Wall Street RDFN Redfin $76.64 / -0.08 (-0.10%) 12/28/20 Redfin put volume heavy and directionally bearish 12/09/20 Redfin call volume above normal and directionally bullish 10/15/20 Redfin put volume heavy and directionally bearish 09/24/20 Redfin put volume heavy and directionally bearish

Options	Micron call buyer realizes 56% same-day gains » 08:00 01/20/21 01/20 08:00 01/20/21 08:00 MU Micron $85.49 / +4.76 (+5.90%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $85.49 / +4.76 (+5.90%) 01/14/21 Micron director sells 50K shares of common stock 01/13/21 Micron's Arnzen sells 15,000 common shares 01/08/21 Micron CEO: We are in the sweet spot of market trends 01/07/21 Micron says data center revenue declined sequentially in Q1 MU Micron $85.49 / +4.76 (+5.90%) 01/19/21 Mizuho Micron not impacted by Xiaomi blacklist, says Mizuho 01/11/21 Citi December notebook shipments good news for Micron and Intel, says Citi 01/08/21 JPMorgan Micron price target raised to $100 from $85 at JPMorgan 01/08/21 Wells Fargo Wells Fargo says Micron remains 2021 Top Pick after Q1 report MU Micron $85.49 / +4.76 (+5.90%) 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close 12/01/20 Micron raises Q1 adj. EPS view 69c-73c from 40c-54c, consensus 48c MU Micron $85.49 / +4.76 (+5.90%) 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says MU Micron $85.49 / +4.76 (+5.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: What to watch in Micron's earnings report 02/11/21 Technology & Internet Virtual Conference MU Micron $85.49 / +4.76 (+5.90%) 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish 01/05/21 Early notable gainers among liquid option names on January 5th 01/05/21 Unusually active option classes on open January 5th
Earnings	BOK Financial reports Q4 EPS $2.21, consensus $1.92 » 07:59 01/20/21 01/20 07:59 01/20/21 07:59 BOKF BOK Financial $80.44 / +1.37 (+1.73%) The company's common… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events BOKF BOK Financial $80.44 / +1.37 (+1.73%) 01/04/21 Wells Fargo BOK Financial upgraded to Overweight from Equal Weight at Wells Fargo 10/26/20 Truist BOK Financial price target raised to $69 from $60 at Truist 10/22/20 RBC Capital BOK Financial price target raised to $66 from $60 at RBC Capital 03/09/20 Raymond James BOK Financial downgraded at Raymond James as oil prices sink BOKF BOK Financial $80.44 / +1.37 (+1.73%) 10/21/20 BOK Financial reports Q3 EPS $2.19, consensus $1.56 07/22/20 BOK Financial reports Q2 EPS 92c, consensus $1.12 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 10:00 Today BOK Financial - BOKF
Initiation	Nidec initiated with a Buy at Jefferies » 07:59 01/20/21 01/20 07:59 01/20/21 07:59 NJDCY Nidec $0.00 / + (+0.00%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News NJDCY Nidec $0.00 / + (+0.00%) 01/19/21 Nidec files patent infringement suit against Seagate
Recommendations	Arch Resources price target raised to $72 from $68 at B. Riley Securities » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 ARCH Arch Resources $52.09 / +1.6 (+3.17%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ARCH Arch Resources $52.09 / +1.6 (+3.17%) 10/22/20 Arch Resources announces strategic plan for legacy thermal assets 09/02/20 Ramaco Resources appoints Barkley Sturgill as general counsel ARCH Arch Resources $52.09 / +1.6 (+3.17%) 01/15/21 B. Riley Securities Arch Resources price target raised to $68 from $66 at B. Riley Securities 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 06/30/20 B. Riley FBR Arch Resources price target lowered to $67 from $73 at B. Riley FBR 04/27/20 Jefferies Jefferies sees coal mining equities lagging, cuts ratings on three miners ARCH Arch Resources $52.09 / +1.6 (+3.17%) 10/22/20 Arch Resources reports Q3 EPS ($12.64), consensus ($1.04) 07/28/20 Arch Resources reports Q2 EPS ($3.26), consensus ($2.55)
Recommendations	Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 10/22/20 Freeport McMoRan: Makes more sense to develop mines than buy assets 10/22/20 Freeport McMoRan will be 'comfortable' when net debt falls to $5B 10/22/20 Freeport 'confident' in ability to recommend restored dividend in 2021 10/22/20 Freeport McMoRan: No decision yet on new smelter plan in Indonesia FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities 01/05/21 Argus upgrades Freeport McMoRan to Buy on recovery in manufacturing and metals FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open 07/23/20 Freeport McMoRan reports Q2 EPS 3c, consensus (2c) FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 11/11/20 Fly Intel: After-Hours Movers 01/26/21 Freeport McMoRan - FCX FCX Freeport McMoRan $31.70 / +1.34 (+4.41%) 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st 12/30/20 Freeport McMoRan call volume above normal and directionally bullish

Initiation	Sapiens initiated with a Buy at Jefferies » 07:58 01/20/21 01/20 07:58 01/20/21 07:58 SPNS Sapiens $31.51 / +0.49 (+1.58%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SPNS Sapiens $31.51 / +0.49 (+1.58%) 12/16/20 Sapiens partners with TruthMD for advanced data analytics 11/09/20 Sapiens acquires Tia Technology, terms not disclosed 09/24/20 Sapiens partners with GreenRoad Technologies for auto insurance solution 09/08/20 Sapiens appoints Jeannine Sargent to its board of director SPNS Sapiens $31.51 / +0.49 (+1.58%) 01/13/21 Fly Intel: Top five analyst initiations 01/13/21 Goldman Sachs Sapiens initiated with a Neutral at Goldman Sachs 12/22/20 Fly Intel: Top five analyst initiations 12/22/20 Citi Sapiens initiated with a Buy at Citi SPNS Sapiens $31.51 / +0.49 (+1.58%) 08/04/20 Sapiens raises FY20 revenue view to $376M-$381M from $368M-$377M 08/04/20 Sapiens reports Q2 EPS 26c, consensus 21c 16 Oct SPNS Sapiens $31.51 / +0.49 (+1.58%) 10/13/20 Fly Intel: After-Hours Movers
Recommendations	Comerica price target raised to $72 from $65 at B. Riley Securities » 07:57 01/20/21 01/20 07:57 01/20/21 07:57 CMA Comerica $63.85 / +0.16 (+0.25%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CMA Comerica $63.85 / +0.16 (+0.25%) 08/19/20 Comerica partners with Minority Depository Institutions 07/21/20 Comerica up 4.8% after reporting Q2 results CMA Comerica $63.85 / +0.16 (+0.25%) 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/13/21 Baird Comerica downgraded to Neutral following rally at Baird 01/13/21 Baird Comerica downgraded to Neutral from Outperform at Baird CMA Comerica $63.85 / +0.16 (+0.25%) 01/19/21 Comerica reports Q4 EPS $1.49, consensus $1.19 10/20/20 Comerica reports Q3 EPS $1.44, consensus 83c 07/21/20 Comerica reports Q2 EPS 80c, consensus 21c 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 04/20/21 Comerica - CMA CMA Comerica $63.85 / +0.16 (+0.25%) 10/20/20 Early notable gainers among liquid option names on October 20th
Recommendations	Zions Bancorp price target raised to $57 from $55 at B. Riley Securities » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 ZION Zions Bancorp $49.35 / +0.19 (+0.39%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/07/21 B. Riley Securities Zions Bancorp price target raised to $55 from $52 at B. Riley Securities 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight with $50 target at Barclays 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight from Overweight at Barclays 12/07/20 Evercore ISI Zions Bancorp upgraded to Outperform from In Line at Evercore ISI ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Zions Bancorp reports Q4 EPS $1.66, consensus $1.02 01/19/21 Notable companies reporting after market close 10/19/20 Zions Bancorp reports Q3 EPS $1.01, consensus 88c 07/20/20 Zions Bancorp reports Q2 EPS 34c, consensus 38c ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 04/19/21 Zions Bancorp - ZION ZION Zions Bancorp $49.35 / +0.19 (+0.39%) 01/19/21 Zions Bancorp options imply 4.3% move in share price post-earnings
Upgrade	Pola Orbis upgraded to Buy from Hold at Jefferies » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 PORBF Pola Orbis / + Jefferies analyst Mitsuko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PORBF Pola Orbis / + 01/07/21 Goldman Sachs Pola Orbis upgraded to Buy from Neutral at Goldman Sachs
Downgrade	Ceragon Networks double-downgraded to Underperform from Buy at Needham » 07:56 01/20/21 01/20 07:56 01/20/21 07:56 CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) Needham analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 09/16/20 Ceragon Networks' new quad-carrier outdoor solution selected by 5G providers 08/03/20 Ceragon Networks selected by Orange Niger for 4G deployment support CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 07:17 Today Needham Ceragon Networks downgraded to Underperform from Buy at Needham 05/04/20 Needham Ceragon longer-term news continues to improve, says Needham 04/17/20 Needham Ceragon Networks upgraded to Buy from Hold at Needham 04/17/20 Needham Ceragon Networks upgraded to Buy from Hold at Needham CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 11/02/20 Ceragon Networks reports Q3 EPS 3c, consensus (1c) 08/03/20 Ceragon Networks reports Q2 EPS (6c), consensus (7c) 02/08/21 Ceragon Networks - CRNT

Events

Earnings calls, analyst events, roadshows and more

FNB
Today at 08:15

F.N.B. - FNB Conference Calls
MS
Today at 08:30

Morgan Stanley - MS Conference Calls
PG
Today at 08:30

Procter & Gamble - PG Conference Calls
UNH
Today at 08:45

UnitedHealth - UNH Conference Calls
Today at 08:55

Redbook Store Sales Y/Y: 1/16/21 Government Event
USB
Today at 09:00

U.S. Bancorp - USB Conference Calls
PNFP
Today at 09:30

Pinnacle Financial - PNFP Conference Calls
NJR
Today at 09:30

New Jersey Resources Corp Firm Sponsored Meetings
Today at 10:00

Housing Market Index: January 2021 Government Event
BOKF
Today at 10:00

BOK Financial - BOKF Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel $22.00-23.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE $13.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

JPMorgan backs Neutral on Intrum after Q2 pre-announcement

TODAY'S FREE FLY STORIES

Get Full Fly Access